MENTAX Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Mentax, and when can generic versions of Mentax launch?

Mentax is a drug marketed by Mylan and is included in two NDAs.

The generic ingredient in MENTAX is butenafine hydrochloride. There are two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Mentax

A generic version of MENTAX was approved as butenafine hydrochloride by TARO on November 16^th, 2017.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for MENTAX?
What are the global sales for MENTAX?
What is Average Wholesale Price for MENTAX?

Summary for MENTAX

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	104
Patent Applications:	321
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for MENTAX
What excipients (inactive ingredients) are in MENTAX?	MENTAX excipients list
DailyMed Link:	MENTAX at DailyMed

Drug patent expirations by year for MENTAX

US Patents and Regulatory Information for MENTAX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan	MENTAX	butenafine hydrochloride	CREAM;TOPICAL	020524-001	Oct 18, 1996		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan	MENTAX-TC	butenafine hydrochloride	CREAM;TOPICAL	021408-001	Oct 17, 2002		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for MENTAX

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mylan	MENTAX	butenafine hydrochloride	CREAM;TOPICAL	020524-001	Oct 18, 1996	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for MENTAX

See the table below for patents covering MENTAX around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Hong Kong	111793	AMINE DERIVATIVES,PROCESSES FOR PREPARING THE SAME AND FUNGICIDES CONTAINING THE SAME	⤷ Sign Up
Japan	H02209848	NAPHTHYLMETHYLAMINE DERIVATIVE AND ANTIFUNGAL AGENT CONTAINING THE SAME DERIVATIVE AS ACTIVE INGREDIENT	⤷ Sign Up
China	85104330		⤷ Sign Up
European Patent Office	0164697	AMINE DERIVATIVES, PROCESSES FOR PREPARING THE SAME AND FUNGICIDES CONTAINING THE SAME	⤷ Sign Up
Luxembourg	91031		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for MENTAX

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0164697	91031	Luxembourg	⤷ Sign Up	91031, EXPIRES: 20100606
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for MENTAX

Make Better Decisions: Try a trial or see plans & pricing